Skip to content

Optimising optometric practice provided to people with age-related macular degeneration (AMD)

Assessing improvements in Australian optometrists’ knowledge and management of Age-related macular degeneration (AMD) using in-office interventions in a randomised controlled study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001747112
Enrollment
31
Registered
2019-12-10
Start date
2019-12-10
Completion date
2020-07-17
Last updated
2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project focuses on investigating the implementation of a set of new clinical tools, for intended in-office use by optometrists, to support best-practice care provision to people with AMD. We are also aiming to support and engage optometrists to audit their own clinical practices, using the Macular Degeneration Clinical Care Audit Tool (MaD-CCAT), which we previously developed with funding support from the Macular Disease Foundation of Australia. We expect these tools will result in an improvement in accurate classification of AMD severity and management advice provided to patients with AMD to ensure consistency in optometric practice, and in the longer-term may have the capacity to be disseminated both nationally and internationally.

Interventions

Intervention 1: Classification of Age-related macular degeneration and Risk Assessment Tool (CARAT) online intervention. Description: This arm will be assigned an online intervention (the CARAT tool) that will assist optometrists with calculating a patient’s risk of progression to late-stage AMD, based on patient risk factors and clinical signs. Participants (optometrists) will need to enter information regarding their patient’s risk factors (such as age, family history of AMD, current smoking

Intervention 1: Classification of Age-related macular degeneration and Risk Assessment Tool (CARAT) online intervention. Description: This arm will be assigned an online intervention (the CARAT tool) that will assist optometrists with calculating a patient’s risk of progression to late-stage AMD, based on patient risk factors and clinical signs. Participants (optometrists) will need to enter information regarding their patient’s risk factors (such as age, family history of AMD, current smoking status and presence of reticular pseudodrusen) and clinical signs (such as size of drusen, AMD pigmentary changes) which will assist in classifying the severity of AMD, calculating the risk of progression to late-stage AMD, and providing appropriate management advice to patients (including review periods). A link to a supporting document will provide participants with further information to assist with managing a patient with AMD. In-office use of the online tool should take the optometrist 2-3 minutes. It is intended to be used with the patient, towards the end of the clinical examination whilst discussing clinical management. The CARAT online tool and the supporting document were designed specifically for this project and are not generally available. Participants will not receive a summary of their input but are required to enter their management recommendations in their patient clinical records, as per standard practice. Intervention 2: : Classification of Age-related macular degeneration and Risk Assessment Tool (CARAT) paper-based intervention. This arm will be assigned a similar intervention to Arm 1, however it will be delivered in a paper-based format. Participants will be provided with a flowchart to use when managing a patient with AMD. The chart will begin with information regarding patient’s risk factors including age, family history of AMD, current smoking status and presence of reticular pseudodrusen. The second part of the chart provides optometrists with a flowchart to classify AMD severity based on clinical signs and leads to an appropriate management recommendation. Arm 2 will also be provided with the same supporting manual as Arm 1, but in a paper-based form. In-office use of the paper-based tool should take the optometrist about 2-3 minutes. It is intended to be used with the patient, towards the end of the clinical examination whilst discussing clinical management. The CARAT paper-based tool and the supporting documentation weres designed specifically for this project and are not generally available. Participants will not receive a summary of their input but are required to enter their management recommendations, in their patient clinical records, as per standard practice.

Sponsors

The University of Melbourne
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

- AHPRA registered optometrists - Currently practicing optometry in Australia - Currently providing clinical care to patients with AMD - Have access to their own clinical records

Exclusion criteria

- Currently practicing optometry overseas

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026